NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Major histocompatibility complex (MHC) molecules are expressed on the cell surface, where they present peptides to T cells, which gives them a key role in the development of T-cell immune responses. MHC molecules come in two main variants: MHC Class I (MHC-I) and MHC Class II (MHC-II). MHC-I predominantly present peptides derived from intracellular proteins, whereas MHC-II predominantly presents peptides from extracellular proteins. In both cases, the binding between MHC and antigenic peptides is the most selective step in the antigen presentation pathway. Therefore, the prediction of peptide binding to MHC is a powerful utility to predict the possible specificity of a T-cell immune response. Commonly MHC binding prediction tools are trained on binding affinity or mass spectrometry-eluted ligands. Recent studies have however demonstrated how the integration of both data types can boost predictive performances. Inspired by this, we here present NetMHCpan-4.1 and NetMHCIIpan-4.0, two web servers created to predict binding between peptides and MHC-I and MHC-II, respectively. Both methods exploit tailored machine learning strategies to integrate different training data types, resulting in state-of-the-art performance and outperforming their competitors. The servers are available at http://www.cbs.dtu.dk/services/NetMHCpan-4.1/ and http://www.cbs.dtu.dk/services/NetMHCIIpan-4.0/.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Among these tools, NetMHCpan stands out in predicting the binding affinity between peptides and MHC-I/II, respectively [139].”
From Single-cell sequencing to multi-omics: technologies and applications (2024) · cites this paper as [139]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jurtz, V., Paul, S., Andreatta, M., Marcatili, P., Peters, B., & Nielsen, M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700893 · Cited by 1,470
Self-citationImproved methods for predicting peptide binding affinity to MHC class II molecules
Jensen, K. K., Andreatta, M., Marcatili, P., Buus, S., Greenbaum, J. A., Yan, Z., Sette, A., Peters, B., & Nielsen, M. (2018) · Immunology · doi:10.1111/imm.12889 · Cited by 794
Self-citationAbelin, J. G., Keskin, D. B., Sarkizova, S., Hartigan, C. R., Zhang, W., Sidney, J., Stevens, J., Lane, W., Zhang, G. L., Eisenhaure, T. M., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.02.007 · Cited by 617
Nielsen, M., & Andreatta, M. (2016) · Genome Medicine · doi:10.1186/s13073-016-0288-x · Cited by 517
Self-citationSarkizova, S., Klaeger, S., Le, P. M., Li, L. W., Oliveira, G., Keshishian, H., Hartigan, C. R., Zhang, W., Braun, D. A., Ligon, K. L., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-019-0322-9 · Cited by 499
Reynisson, B., Barra, C., Kaabinejadian, S., Hildebrand, W. H., Peters, B., & Nielsen, M. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00874 · Cited by 445
Self-citationMHCflurry: Open-Source Class I MHC Binding Affinity Prediction
O'Donnell, T. J., Rubinsteyn, A., Bonsack, M., Riemer, A. B., Laserson, U., & Hammerbacher, J. (2018) · Cell Systems · doi:10.1016/j.cels.2018.05.014 · Cited by 409
Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification
Bulik-Sullivan, B., Busby, J., Palmer, C. D., Davis, M. J., Murphy, T., Clark, A., Busby, M., Duke, F., Yang, A., Young, L., et al. (2019) · Nature Biotechnology · doi:10.1038/nbt.4313 · Cited by 307
Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes
Racle, J., Michaux, J., Rockinger, G. A., Arnaud, M., Bobisse, S., Chong, C., Guillaume, P., Coukos, G., Harari, A., Jandus, C., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0289-6 · Cited by 289
Karosiene, E., Rasmussen, M., Blicher, T., Lund, O., Buus, S., & Nielsen, M. (2013) · Immunogenetics · doi:10.1007/s00251-013-0720-y · Cited by 272
Self-citation
Research works printed but not linked: 1
- O’Donnell T.J., Rubinsteyn A., Bonsack M., Riemer A.B., Laserson U., Hammerbacher J. 2020; MHCFlurry https://github.com/openvax/mhcflurry. 29960884
Cited by
Items 401–500 of 1,014
Li, X., Kaboli, P. J., Roozitalab, G., Salahi, S., Qian, H., Zhang, X., Chen, K., & İmani, S. (2026) · Cellular Oncology · doi:10.1007/s13402-026-01199-1 · Cited by 25
Automated Ligand Purification Platform Accelerates Immunopeptidome Analysis by Mass Spectrometry
Zhang, L., McAlpine, P. L., Heberling, M. L., & Elias, J. E. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00464 · Cited by 25
Naito, T., Satake, W., Ogawa, K., Ken, S., Hirata, J., Foo, J. N., Tan, E., Toda, T., & Okada, Y. (2021) · Movement Disorders · doi:10.1002/mds.28583 · Cited by 25
Mangalaparthi, K. K., Madugundu, A. K., Ryan, Z. C., Garapati, K., Peterson, J. A., Dey, G., Prakash, A., & Pandey, A. (2021) · Journal of Proteins and Proteomics · doi:10.1007/s42485-021-00066-x · Cited by 25
Brito, C., Tomás, A., Azevedo, A., Esteves, S., Mafra, M., Roque, L., & Pojo, M. (2022) · Clinical Medicine Insights Oncology · doi:10.1177/11795549211068804 · Cited by 25
Tuning DO:DM Ratios Modulates MHC Class II Immunopeptidomes
Olsson, N., Jiang, W., Adler, L. N., Mellins, E., & Elias, J. E. (2022) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2022.100204 · Cited by 25
Long, Y., Sun, J., Song, T., Liu, T., Tang, F., Zhang, X., Ding, L., Miao, Y., Zhu, W., Pan, X., et al. (2022) · Cell Discovery · doi:10.1038/s41421-021-00370-2 · Cited by 25
The role of antigen expression in shaping the repertoire of HLA presented ligands
Alvarez, H. M. G., Koşaloğlu‐Yalçın, Z., Peters, B., & Nielsen, M. (2022) · iScience · doi:10.1016/j.isci.2022.104975 · Cited by 25
Self-citationPGNneo: A Proteogenomics-Based Neoantigen Prediction Pipeline in Noncoding Regions
Tan, X., Xu, L., Jian, X., Ouyang, J., Hu, B., Yang, X., Wang, T., & Xie, L. (2023) · Cells · doi:10.3390/cells12050782 · Cited by 25
Kim, J. J., Fichtner, A., Copley, H. C., Gragert, L. A., Süsal, C., Strologo, L. D., Oh, J. S., Pape, L., Weber, L. T., Weitz, M., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1092335 · Cited by 25
Evaluating NetMHCpan performance on non-European HLA alleles not present in training data
Atkins, T. K., Solanki, A., Vasmatzis, G., Cornette, J. L., & Riedel, M. D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1288105 · Cited by 25
Stejskal, L., Thistlethwaite, A., Bencomo, F. R., Rashmi, S., Harrison, O. B., Feavers, I. M., Maiden, M. C. J., Jerse, A. E., Barnes, G., Chirro, O., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51053-x · Cited by 25
An integrated approach for characterizing immunogenic responses toward a bispecific antibody
Cohen, S., Chung, S., Spiess, C., Lundin, V., Stefanich, E. G., Laing, S. T., Clark, V., Brumm, J., Zhou, Y., Huang, C., et al. (2021) · mAbs · doi:10.1080/19420862.2021.1944017 · Cited by 25
In Vitro Anti-Inflammatory Activity of Three Peptides Derived from the Byproduct of Rice Processing
Qu, T., He, S., Ni, C., Wu, Y., Xu, Z., Chen, M., Li, H., Cheng, Y., & Li, W. (2022) · Plant Foods for Human Nutrition · doi:10.1007/s11130-022-00963-6 · Cited by 25
The Role of AI-Driven De Novo Protein Design in the Exploration of the Protein Functional Universe
Zhang, G., Liu, C., Lu, J., Zhang, S., & Zhu, L. (2025) · Biology · doi:10.3390/biology14091268 · Cited by 24
Progress in cancer vaccines enabled by nanotechnology
Kim, B., Abdelfattah, N. S., Hostetler, A., & Irvine, D. J. (2025) · Nature Nanotechnology · doi:10.1038/s41565-025-02021-z · Cited by 24
Emadi, S. H., Ahmad, S., Rahmanian, M., Baharlou, R., Ahmad, F., Aghaamoo, S., & Sanami, S. (2026) · Virology Journal · doi:10.1186/s12985-026-03072-x · Cited by 24
Scalable TCR synthesis and screening enable antigen reactivity mapping in vitiligo
Gaglione, S. A., Mukkamala, R. S., Krishna, C., Smith, B. E., Wadsworth, M. H., Jelinsky, S. A., Perez, C. R., Schmidt-Hong, L., Katz, E. L., Gellatly, K. J., et al. (2026) · Immunity · doi:10.1016/j.immuni.2026.01.001 · Cited by 24
Li, Y., Wang, X., Jin, J., Ma, Z., Liu, Y., Zhang, X., & Su, B. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27814 · Cited by 24
Tzeng, T.-T., Chai, K. M., Shen, K., Yu, C.-Y., Yang, S.-J., Huang, W., Liao, H., Chiu, F., Dou, H.-Y., Liao, C., et al. (2022) · npj Vaccines · doi:10.1038/s41541-022-00482-0 · Cited by 24
Fonseca, A. F., & Antunes, D. A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1142573 · Cited by 24
Advances in vaccine development for cancer prevention and treatment in Lynch Syndrome
Bolívar, A. M., Düzağaç, F., Sinha, K. M., & Vilar, E. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101204 · Cited by 24
Kobayashi, S., Tokita, S., Moniwa, K., Kitahara, K., Iuchi, H., Matsuo, K., Κakizaki, H., Kanaseki, T., & Torigoe, T. (2023) · JCI Insight · doi:10.1172/jci.insight.167712 · Cited by 24
Qu, W., You, R., Mamitsuka, H., & Zhu, S. (2023) · Bioinformatics · doi:10.1093/bioinformatics/btad551 · Cited by 24
Li, B., Jing, P., Zheng, G., Pi, C., Zhang, L., Yin, Z., Xu, L., Qiu, J., Gu, H., Qiu, T., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01644-9 · Cited by 25
Li, Y., Farhan, M. H. R., Yang, X., Guo, Y., Sui, Y., Chu, J., Huang, L., & Cheng, G. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.136827 · Cited by 24
(2024) · doi:10.1128/msphere.00799-23 · Cited by 23
Jiang, D., Xi, B., Tan, W., Chen, Z., Wei, J., Hu, M., Lu, X., Chen, D., Cai, H., & Du, H. (2024) · Bioinformatics · doi:10.1093/bioinformatics/btae547 · Cited by 23
“…have been mostly restricted to predicting the binding of pHLA complexes or analyzing the sequence of mutant peptides, which is necessary but not sufficient (Bassani-Sternberg et al. 2017, Łuksza et al. 2017, Richman et al. 2019, O’Donnell et al. 2020, Reynisson et al. 2020, Kim et al. 2023).”
BackgroundYu, C., Fang, X., Tian, S., & Liu, H. (2025) · Nature Machine Intelligence · doi:10.1038/s42256-024-00973-w · Cited by 23
Lin, Z., Liu, X., Wang, H., Li, S., Miao, Z., Yang, J., Zhang, Y., Lei, K., Wu, Y., Kang, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61448-z · Cited by 23
T cell receptor specificity landscape revealed through de novo peptide design
Visani, G. M., Pun, M. N., Minervina, A. A., Bradley, P. H., Thomas, P. G., & Nourmohammad, A. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2504783122 · Cited by 23
Intron-Retention Neoantigen Load Predicts Favorable Prognosis in Pancreatic Cancer
Dong, C., Reiter, J. L., Dong, E., Wang, Y., Lee, K. P., Lu, X., & Liu, Y. (2022) · JCO Clinical Cancer Informatics · doi:10.1200/cci.21.00124 · Cited by 23
Chen, Y., Mason, G. H., Scourfield, D. O., Greenshields‐Watson, A., Haigh, T. A., Sewell, A. K., Long, H. M., Gallimore, A., Rizkallah, P. J., MacLachlan, B. J., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112827 · Cited by 23
Farias, T. D. J., Brugiapaglia, S., Croci, S., Magistroni, P., Curcio, C., Zguro, K., Fallerini, C., Fava, F., Pettini, F., Kichula, K. M., et al. (2023) · HLA · doi:10.1111/tan.15251 · Cited by 23
In silico design of a broad-spectrum multiepitope vaccine against influenza virus
Yuan, L., Li, X., Li, M., Bi, R., Li, Y., Song, J., Li, W., Yan, M., Luo, H., Sun, C., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128071 · Cited by 23
Dai, J., Izadi, S., Zarzar, J., Wu, P., Oh, A., & Carter, P. J. (2024) · mAbs · doi:10.1080/19420862.2024.2304282 · Cited by 23
Kirk, A. M., Crawford, J. C., Chou, C., Guy, C. S., Pandey, K., Kozlik, T., Shah, R. K., Chung, S., Nguyen, P., Zhang, X., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101469 · Cited by 23
Ancient genomes reveal insights into ritual life at Chichén Itzá
Barquera, R., Chávez, O. D. C., Nägele, K., Pérez-Ramallo, P., Hernández-Zaragoza, D. I., Szolek, A., Rohrlach, A. B., Librado, P., Childebayeva, A., Bianco, R. A., et al. (2024) · Nature · doi:10.1038/s41586-024-07509-7 · Cited by 23
Development of a novel multi-epitope vaccine for brucellosis prevention
Shang, K., Zhu, Y., Tian, T., Shi, H., Yin, Z., He, Y., Shi, J., Ding, J., & Zhang, F. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34721 · Cited by 23
Parvin, R., Masum, M. H. U., Ferdous, J., Mahdeen, A. A., & Khan, M. S. I. (2024) · PLoS ONE · doi:10.1371/journal.pone.0310398 · Cited by 23
Shvefel, S. C., Pai, J. A., Cao, Y., Pal, L. R., Bartok, O., Levy, R., Zemanek, M. J., Weller, C., Herzog, E., Yao, W., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-1422 · Cited by 23
Invenção, M. D. C. V., de Macêdo, L. S., de Moura, I. A., Santos, L. A. B. D. O., Espinoza, B. C. F., de Pinho, S. S., Leal, L. R. S., dos Santos, D. L., Marcos, B. D. F. S., Elsztein, C., et al. (2025) · Vaccines · doi:10.3390/vaccines13020149 · Cited by 23
Sharma, A. D., Magdaleno, J. S. L., Singh, H., Orduz, A. F. C., Cavallo, L., & Chawla, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-95256-8 · Cited by 23
APOBEC affects tumor evolution and age at onset of lung cancer in smokers
Zhang, T., Sang, J., Hoang, P. H., Wei, Z., Rosenbaum, J., Johnson, K. E., Klimczak, L. J., McElderry, J. P., Klein, A., Wirth, C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59923-8 · Cited by 23
Norovirus-Specific CD8+ T Cell Responses in Human Blood and Tissues
Pattekar, A., Mayer, L., Lau, C. W., Liu, C., Palko, O., Bewtra, M., Lindesmith, L. C., Brewer-Jensen, P. D., Baric, R. S., Betts, M. R., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.12.012 · Cited by 23
Leveraging Immunopeptidomics To Study and Combat Infectious Disease
Leddy, O. K., White, F. M., & Bryson, B. D. (2021) · mSystems · doi:10.1128/msystems.00310-21 · Cited by 23
Rodríguez-Enríquez, A., Camacho, I. H., Millán-Pérez-Peña, L., Reyes‐Leyva, J., Santos‐López, G., Rivera-Benítez, J. F., & Rosas-Murrieta, N. H. (2022) · PLoS ONE · doi:10.1371/journal.pone.0263582 · Cited by 23
Burkholz, S., Herst, C. V., Carback, R. T., Harris, P. E., & Rubsamen, R. (2023) · Vaccines · doi:10.3390/vaccines11030644 · Cited by 23
Computational Methods in Immunoinformatics: Epitope Discovery and Diagnostic Applications
Bulla, A. C. S., da Silva, A. S., Sereno, B. P., Dias, M. F. R., & da Silva, M. L. (2025) · ACS Omega · doi:10.1021/acsomega.5c05538 · Cited by 22
Borden, E. S., Ghafoor, S., Buetow, K. H., LaFleur, B., Wilson, M. A., & Hastings, K. T. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2100700 · Cited by 22
Hernandez, S. P. A., Hersby, D. S., Munk, K. K., Tamhane, T., Trubach, D., Tagliamonte, M., Buonaguro, L., Gang, A. O., Hadrup, S. R., & Saini, S. K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1035344 · Cited by 22
A comprehensive assessment and comparison of tools for HLA class I peptide-binding prediction
Wang, M., Kurgan, L., & Li, M. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad150 · Cited by 22
Neodb: a comprehensive neoantigen database and discovery platform for cancer immunotherapy
Wu, T., Chen, J., Diao, K., Wang, G., Wang, J., Yao, H., & Liu, X. (2023) · Database · doi:10.1093/database/baad041 · Cited by 22
Yaseen, A. R., Suleman, M., Qadri, A. S., Ali, A., Arshad, I., & Khan, D. M. (2023) · In Silico Pharmacology · doi:10.1007/s40203-023-00156-2 · Cited by 22
Boll, L. M., Perera‐Bel, J., Rodríguez‐Vida, A., Arpí, O., Rovira, A., Juanpere-Rodero, N., de Oca, S. V. M., Hernández‐Llodrà, S., Lloreta, J., Albà, M. M., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-42495-2 · Cited by 22
Riding the wave of innovation: immunoinformatics in fish disease control
Razali, S. A., Shamsir, M. S., Ishak, N. F., Low, C. F., & Azemin, W.-A. (2023) · PeerJ · doi:10.7717/peerj.16419 · Cited by 22
Wei, F., Kouro, T., Nakamura, Y., Ueda, H., Iiizumi, S., Hasegawa, K., Asahina, Y., Kishida, T., Morinaga, S., Himuro, H., et al. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2024.01.023 · Cited by 22
HIV-1 Gag, Pol, and Env diversified with limited adaptation since the 1980s
Lewitus, É., Li, Y., Bai, H., Pham, P. T., & Rolland, M. (2024) · mBio · doi:10.1128/mbio.01749-23 · Cited by 22
T cell help shapes B cell tolerance
Akama‐Garren, E. H., Yin, X., Prestwood, T. R., Ma, M., Utz, P. J., & Carroll, M. C. (2024) · Science Immunology · doi:10.1126/sciimmunol.adj7029 · Cited by 22
Liu, X., Zheng, X., Shu, Y., Qu, X., Wang, Q., Liu, X., Hu, F., Liu, J., Lian, Y., He, B.-M., et al. (2024) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200221 · Cited by 22
Kristensen, N. P., Dionisio, E., Bentzen, A. K., Tamhane, T., Kemming, J. S., Nos, G., Voss, L. F., Hansen, U. K., Lauer, G. M., & Hadrup, S. R. (2024) · Science Advances · doi:10.1126/sciadv.adm8951 · Cited by 22
Design and evaluation of a multi-epitope DNA vaccine against HPV16
Zhu, L., Cui, X., Yan, Z., Tao, Y., Shi, L., Zhang, X., Yao, Y., & Shi, L. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2352908 · Cited by 22
Banico, E. C., Sira, E. M. J. S., Fajardo, L. E., Dulay, A. N. G., Odchimar, N. M. O., Simbulan, A. M., & Orosco, F. L. (2024) · PLoS ONE · doi:10.1371/journal.pone.0310703 · Cited by 22
Rahman, E., Peng, H. P., Wu, W. T. L., & Webb, W. R. (2025) · European Journal of Plastic Surgery · doi:10.1007/s00238-025-02311-8 · Cited by 22
Stamatakis, G. M., Samiotaki, M. K., Mpakali, A., Panayotou, G., & Stratikos, E. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00457 · Cited by 22
Neoantigen vaccine: An emerging immunotherapy for hepatocellular carcinoma
Chen, P., Fang, Q., Chen, D., & Chen, H. (2021) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v13.i7.673 · Cited by 22
A Highly Effective System for Predicting MHC-II Epitopes With Immunogenicity
Xu, S., Wang, X. H., & Fei, C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.888556 · Cited by 22
Vigón, L., Galán, M., Torres, M., Martín-Galiano, A. J., Rodríguez-Mora, S., Mateos, E., Corona, M., de Molina, R. M., Navarro, C., Murciano-Antón, M. A., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272867 · Cited by 22
Champagne, J., Nielsen, M. M., Feng, X., Navarro, J. M., Pataskar, A., Voogd, R., Giebel, L., Nagel, R., Berenst, N., Fumagalli, A., et al. (2025) · Immunity · doi:10.1016/j.immuni.2024.12.004 · Cited by 21
Self-citationKessler, A. L., Pieterman, R. F. A., Doff, W. A. S., Bezstarosti, K., Bouzid, R., Klarenaar, K., Jansen, D. T. S. L., Luijten, R. J., Demmers, J., & Buschow, S. I. (2025) · npj Vaccines · doi:10.1038/s41541-025-01069-1 · Cited by 21
Immunoinformatic-driven design and evaluation of multi-epitope mRNA vaccine targeting HIV-1 gp120
Ahmed, M. Z., Rao, T., Mutahir, Z., Ahmed, S., Ullah, N., & Ojha, S. C. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1480025 · Cited by 21
Self-iterative multiple-instance learning enables the prediction of CD4+ T cell immunogenic epitopes
Shen, L.-C., Zhang, Y., Wang, Z., Littler, D. R., Liu, Y., Tang, J., Rossjohn, J., Yu, D., & Song, J. (2025) · Nature Machine Intelligence · doi:10.1038/s42256-025-01073-z · Cited by 21
Grudzinska‐Goebel, J., Braun, M., Chen, L., Gupta, S., Lohmann, S., Morais, P., Niu, T., Tarcsa, E., Tourdot, S., Youssef, A. S., et al. (2025) · Nucleic Acid Therapeutics · doi:10.1177/21593337251387423 · Cited by 21
Alshorman, J., Mehran, M. J., Bahrami, Y., Mohammadzadeh, S., Barzigar, R., Morshedi, M., Haider, K. H., Tembo, K. M., Rong, S.-J., Jadgal, N., et al. (2026) · Clinical and Experimental Medicine · doi:10.1007/s10238-026-02107-5 · Cited by 22
Pereira, A. M. M. B., Triunfante, V., Araújo, P. M. M., Martins, J., Soares, H., Poveda, E., Souto, B. G. A., & Osório, N. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105304 · Cited by 21
Heterologous Immunity Between SARS-CoV-2 and Pathogenic Bacteria
Eggenhuizen, P. J., Ng, B. H., Chang, J., Cheong, R. M. Y., Yellapragada, A., Wong, W. Y., Ting, Y. T., Monk, J. A., Gan, P., Holdsworth, S. R., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.821595 · Cited by 21
Oosting, L. T., Franke, K., Martin, M. V., Kloosterman, W. P., Jamieson, J. A., Glenn, L. A., de Jager, M. W., van Zanten, J., Allersma, D. P., & Gareb, B. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071515 · Cited by 21
Merli, P., Crivello, P., Strocchio, L., Pinto, R. M., Algeri, M., Bufalo, F. D., Pagliara, D., Becilli, M., Carta, R., Gaspari, S., et al. (2022) · British Journal of Haematology · doi:10.1111/bjh.18561 · Cited by 21
Definition and Characterization of SOX11-Derived T Cell Epitopes towards Immunotherapy of Glioma
Liu, Y., Keib, A., Neuber, B., Wang, L., Riemer, A. B., Bonsack, M., Hückelhoven‐Krauss, A., Schmitt, A., Müller‐Tidow, C., & Schmitt, M. W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031943 · Cited by 21
Krishnamoorthy, H. R., & Ramanathan, K. (2023) · Vaccines · doi:10.3390/vaccines11030577 · Cited by 21
Dhanushkumar, T., Kamaraj, B., Vasudevan, K., Gopikrishnan, M., Dasegowda, K. R., Rambabu, M., & George Priya Doss, C. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.125209 · Cited by 21
Immunoinformatics Strategy to Develop a Novel Universal Multiple Epitope-Based COVID-19 Vaccine
Khamjan, N. A., Lohani, M., Khan, M. F., Khan, S. A., & Algaissi, A. A. (2023) · Vaccines · doi:10.3390/vaccines11061090 · Cited by 21
HLAEquity: Examining biases in pan-allele peptide-HLA binding predictors
Conev, A., Fasoulis, R., Hall-Swan, S., Ferreira, R., & Kavraki, L. E. (2023) · iScience · doi:10.1016/j.isci.2023.108613 · Cited by 21
Pre-existing SARS-2-specific T cells are predicted to cross-recognize BA.2.86
Sette, A., Sidney, J., & Grifoni, A. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.11.010 · Cited by 21
Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies
Aparicio, B., Theunissen, P., Hervás‐Stubbs, S., Fortes, P., & Sarobe, P. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2303799 · Cited by 21
The physiological interactome of TCR-like antibody therapeutics in human tissues
Marrer‐Berger, E., Nicastri, A., Augustin, A., Kramar, V., Liao, H., Hanisch, L. J., Carpy, A., Weinzierl, T., Durr, E., Schaub, N. A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47062-5 · Cited by 21
Markov, N. S., Ren, Z., Senkow, K. J., Grant, R. A., Gao, C. A., Malsin, E. S., Sichizya, L., Kihshen, H., Helmin, K. A., Jovisic, M., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01914-w · Cited by 22
Strategies to Overcome Hurdles in Cancer Immunotherapy
Kim, J. H., Lee, B. J., Moon, S., Lee, H., Lee, J., Kim, B., Jung, K., Seo, H., & Chung, Y. (2024) · Biomaterials Research · doi:10.34133/bmr.0080 · Cited by 21
Rahman, E., Rao, P., Ahmed, M., Webb, W. R., & CARRUTHERS, J. D. A. (2025) · Toxins · doi:10.3390/toxins17040182 · Cited by 21
Alam, S. S. M., Mir, S. A., Samanta, A., Nayak, B., Ali, S., & Hoque, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-87063-y · Cited by 21
Trentelman, J. J. A., Šíma, R., Krezdorn, N., Tomás‐Cortázar, J., Barriales, D., Takumi, K., Butler, J. M., Sprong, H., Klouwens, M. J., Urbanová, V., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-76268-y · Cited by 21
Weber, Z., Collier, K. A., Tallman, D., Forman, J., Shukla, S. A., Asad, S., Rhoades, J., Freeman, S. S., Parsons, H. A., Williams, N. O., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00895-x · Cited by 21
Kovalchik, K. A., Ma, Q., Wessling, L., Saab, F., Duquette, J. D., Kubiniok, P., Hamelin, D. J., Faridi, P., Li, C., Purcell, A. W., et al. (2021) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2021.100178 · Cited by 21
HLA class II immunogenic mutation burden predicts response to immune checkpoint blockade
Shao, X., Huang, J. C., Niknafs, N., Balan, A., Cherry, C., White, J. R., Velculescu, V. E., Anagnostou, V., & Karchin, R. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.03.013 · Cited by 21
Protein scaffolds in human clinics
Cano‐Garrido, O., Serna, N., Unzueta, U., Parladé, E., Mangues, R., Villaverde, A., & Vázquez, E. (2022) · Biotechnology Advances · doi:10.1016/j.biotechadv.2022.108032 · Cited by 21
Jensen, M. F., & Nielsen, M. (2024) · eLife · doi:10.7554/elife.93934.2 · Cited by 21
Self-citationIdentification of nonsense-mediated decay inhibitors that alter the tumor immune landscapePreprint
Cook, A. L., Sur, S., Dobbyn, L., Watson, E., Cohen, J. D., Ptak, B., Lee, B. S., Paul, S., Hsiue, E. H.-C., Popoli, M., et al. (2024) · eLife · doi:10.7554/elife.95952 · Cited by 21
Self-citationGoud, M. D., Ramos, E., Shah, A. U., & Hemida, M. G. (2025) · Microorganisms · doi:10.3390/microorganisms13102361 · Cited by 20
Artificial intelligence in antibody–drug conjugate development
Wang, Y., Guo, C., & Li, W. (2025) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2025.10.005 · Cited by 20
Individual HLA-A, -B, -C, and -DRB1 Genotypes Are No Major Factors Which Determine COVID-19 Severity
Schetelig, J., Heidenreich, F., Baldauf, H., Trost, S., Falk, B., Hoßbach, C., Real, R. G. L., Roers, A., Lindemann, D., Dalpke, A. H., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.698193 · Cited by 20
Metadata
- Authors
- Reynisson, B., Alvarez, B., Paul, S., Peters, B., & Nielsen, M.
- Affiliations
- Technical University of Denmark (DK)
- National University of General San Martín (AR)
- La Jolla Institute for Immunology (US)
- Corresponding author
- Nielsen, Morten
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-05-14
- Volume
- 48
- Issue
- W1
- Pages
- W449-W454
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC7319546
- OpenAlex
- W3024570138
- Cited by
- 2,361
- References
- 26
- Citations by year
- 2026: 493 · 2025: 550 · 2024: 459 · 2023: 345 · 2022: 250 · 2021: 216 · 2020: 47
- FWCI
- 69.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion, public-domain)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-sa)
- Funders
- National Institutes of Health (75N93019C00001)
- EIT Health (19638)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Machine Learning in Bioinformatics
- Keywords
- MHC-peptide binding prediction, MHC class I, MHC class II, antigen presentation, NetMHCpan, machine learning, web server, T cell response
- MeSH terms
- Machine Learning, Histocompatibility Antigens Class II, Ligands, Peptides, Software, Histocompatibility Antigens Class I, Antigen Presentation, Amino Acid Motifs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.